Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19

M. E. O'Callaghan; A. Jay; G. Kichenadasse; K. L. Moretti

doi:10.1016/j.annonc.2020.09.014

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19

M. E. O'Callaghan
, A. Jay
, G. Kichenadasse
, K. L. Moretti

College of Medicine and Public Health

Research output: Contribution to journal › Comment/debate

8 Citations (Scopus)

Abstract

Recent literature has reported that patients with prostate cancer treated with androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), an observation which has been widely reported by media outlets...

Original language	English
Pages (from-to)	1780-1782
Number of pages	3
Journal	Annals of Oncology
Volume	31
Issue number	12
DOIs	https://doi.org/10.1016/j.annonc.2020.09.014
Publication status	Published - Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Androgen deprivation therapy
SARS-COV-2
COVID-19

Access to Document

10.1016/j.annonc.2020.09.014Licence: In Copyright

Cite this

@article{3b2a8072cb1c4f9d9a4267048c80363f,

title = "Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19",

abstract = "Recent literature has reported that patients with prostate cancer treated with androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), an observation which has been widely reported by media outlets...",

keywords = "Androgen deprivation therapy, SARS-COV-2, COVID-19",

author = "O'Callaghan, \{M. E.\} and A. Jay and G. Kichenadasse and Moretti, \{K. L.\}",

year = "2020",

month = dec,

doi = "10.1016/j.annonc.2020.09.014",

language = "English",

volume = "31",

pages = "1780--1782",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19

AU - O'Callaghan, M. E.

AU - Jay, A.

AU - Kichenadasse, G.

AU - Moretti, K. L.

PY - 2020/12

Y1 - 2020/12

N2 - Recent literature has reported that patients with prostate cancer treated with androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), an observation which has been widely reported by media outlets...

AB - Recent literature has reported that patients with prostate cancer treated with androgen deprivation therapy (ADT) have a lower incidence of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), an observation which has been widely reported by media outlets...

KW - Androgen deprivation therapy

KW - SARS-COV-2

KW - COVID-19

UR - https://www.scopus.com/pages/publications/85096723220

U2 - 10.1016/j.annonc.2020.09.014

DO - 10.1016/j.annonc.2020.09.014

M3 - Comment/debate

C2 - 33007381

AN - SCOPUS:85096723220

SN - 0923-7534

VL - 31

SP - 1780

EP - 1782

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this